DIPHENHYDRAMINE HYDROCHLORIDE; NAPROXEN SODIUM
| Brand name | NAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDE |
|---|---|
| Active ingredient | DIPHENHYDRAMINE HYDROCHLORIDE; NAPROXEN SODIUM |
| Strength | 25MG;220MG |
| Dosage form | TABLET |
| Route | ORAL |
| Modality | Small molecule |
| FDA approval | October 2018 |
| Marketing status | DISCN |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.